Investors Capital Advisory Services’s Gilead Sciences GILD Stock Holding History

Investors Capital Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$793K	Sell	9,527 -3,368	-26%	-$299K	0.15%	185
2016 Q1	$1.18M	Buy	12,895 +1,982	+18%	+$179K	0.24%	118
2015 Q4	$1.1M	Sell	10,913 -3,531	-24%	-$367K	0.21%	131
2015 Q3	$1.42M	Buy	14,444 +586	+4%	+$65.1K	0.28%	83
2015 Q2	$1.62M	Sell	13,858 -2,063	-13%	-$225K	0.3%	75
2015 Q1	$1.56M	Sell	15,921 -2,258	-12%	-$229K	0.29%	78
2014 Q4	$1.71M	Sell	18,179 -2,329	-11%	-$241K	0.33%	64
2014 Q3	$2.18M	Buy	20,508 +3,306	+19%	+$324K	0.43%	39
2014 Q2	$1.43M	Buy	17,202 +2,308	+15%	+$180K	0.23%	116
2014 Q1	$1.05M	Buy	14,894 +2,176	+17%	+$171K	0.23%	126
2013 Q4	$954K	Buy	12,718 +1,458	+13%	+$102K	0.22%	129
2013 Q3	$707K	Sell	11,260 -405	-3%	-$24.2K	0.18%	160
2013 Q2	$597K	Buy	+11,665	New	+$608K	0.18%	161

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Investors Capital Advisory Services's GILD Position: Q2 2016 in Review

Investors Capital Advisory Services reduced its Gilead Sciences (GILD) stake by 26% in Q2 2016, selling an estimated $299K and leaving 9,527 shares worth $793K. The position accounts for 0.15% of the portfolio, ranked #185.

Investors Capital Advisory Services first reported a position in GILD in Q2 2013 and has held it in 13 quarters since. The position peaked at $2.18M in Q3 2014. 1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

Investors Capital Advisory Services held 9,527 shares of Gilead Sciences worth $793K as of Q2 2016.
Investors Capital Advisory Services sold 3,368 Gilead Sciences shares in Q2 2016, an estimated $299K.
Gilead Sciences made up 0.15% of Investors Capital Advisory Services's portfolio in Q2 2016, its #185 holding.
Investors Capital Advisory Services first reported a position in Gilead Sciences in Q2 2013 and has held it in 13 quarters since.
Investors Capital Advisory Services's Gilead Sciences position peaked at $2.18M in Q3 2014.
1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.